Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05086224 · ClinicalTrials.gov registry record · Early Phase 1

Hematoma Block Versus Bier Block for Closed Fracture Reduction

A Early Phase 1 study of Distal Radius Fractures, sponsored by University of Utah.

Active
Registry status
Early Phase 1
Development phase
500
Enrollment target
1
Study location

NCT05086224 is a Early Phase 1 study of Distal Radius Fractures that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 500 participants, above the 71-participant average among 4 other Distal Radius Fractures trials with a reported enrollment target (604% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05086224, a Early Phase 1 study of Distal Radius Fractures, is active but no longer recruiting, sponsored by University of Utah.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The investigators objective of this study is to evaluate the effectiveness of hematoma block versus intravenous regional anesthesia (Bier block) during closed reduction of distal radius fractures.

Conditions Studied

Interventions

  • DRUG Hematoma Local Anesthetic Block Procedure with 1% Lidocaine
  • DRUG Bier Anesthetic Block Procedure with 1% Lidocaine

Study Locations (1)

Utah

  • University of Utah Orthopaedic Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-07-15
Est. Completion 2025-07
Phase Early Phase 1

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT05086224

The ClinicalTrials.gov registry entry for NCT05086224 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 4 other Distal Radius Fractures trials with a reported enrollment target (604% higher). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Distal Radius Fractures appearing as the primary indexed condition, and to 2 interventions - of which Hematoma Local Anesthetic Block Procedure with 1% Lidocaine is the first listed.

NCT05086224 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05086224 about?

NCT05086224 is a clinical study titled "Hematoma Block Versus Bier Block for Closed Fracture Reduction". The investigators objective of this study is to evaluate the effectiveness of hematoma block versus intravenous regional anesthesia (Bier block) during closed reduction of distal radius fractures.

What is the current status of trial NCT05086224?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 500 participants. The study started on 2021-07-15. Estimated completion is 2025-07.

What conditions does trial NCT05086224 study?

This clinical trial studies the following conditions: Distal Radius Fractures.

What interventions are being tested in trial NCT05086224?

The interventions under investigation include: Hematoma Local Anesthetic Block Procedure with 1% Lidocaine (DRUG), Bier Anesthetic Block Procedure with 1% Lidocaine (DRUG).

Who is sponsoring clinical trial NCT05086224?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05086224 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Distal Radius Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.